The enabling technologies needed for PET-based molecular imaging to support drug development.
It is commonly believed that all that is required to effect PET based molecular imaging to support drug development is a cyclotron and a PET scanner. This review itemises the many additional technologies needed to enable the full exploitation of PET for pharmacodynamic and pharmacokinetic measurements of normal and diseased tissues. There are ongoing developments in each area which when integrated add up to significant advances in the quality and value of the resulting data.: